Current Opinions on Optimal Management of Basilar Artery Occlusion: After the BEST of BASICS Survey
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F22%3A00077421" target="_blank" >RIV/65269705:_____/22:00077421 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/22:00128866
Result on the web
<a href="https://www.ahajournals.org/doi/epdf/10.1161/SVIN.122.000538" target="_blank" >https://www.ahajournals.org/doi/epdf/10.1161/SVIN.122.000538</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1161/SVIN.122.000538" target="_blank" >10.1161/SVIN.122.000538</a>
Alternative languages
Result language
angličtina
Original language name
Current Opinions on Optimal Management of Basilar Artery Occlusion: After the BEST of BASICS Survey
Original language description
BACKGROUND:The best management of basilar artery occlusion (BAO) remains uncertain. The BASICS (Basilar Artery InternationalCooperation Study) and the BEST (Basilar Artery Occlusion Endovascular Intervention Versus Standard Medical Treatment)trials reported neutral results. We sought to understand physicians' approaches to BAOs and whether further BAO randomizedcontrolled trials were warranted.METHODS:We conducted an online international survey from January to March 2022 to stroke neurologists and neurointerven-tionalists. Survey questions were designed to examine clinical and imaging parameters under which clinicians would offer (orrescind) a patient with BAO to endovascular therapy (EVT) or best medical management versus enrollment into a randomizedclinical trial.RESULTS:Of>3002 invited participants, 1245 responded (41.4% response rate) from 73 countries, including 54.7% strokeneurologists and 43.6% neurointerventionalists. More than 95% of respondents would offer EVT to patients with BAO, albeitin various clinical circumstances. There were 70.0% of respondents who indicated that the BASICS and BEST trials did notchange their practice. Only 22.1% of respondents would perform EVT according to anterior circulation occlusion criteria. Theselection of patients for BAO EVT by clinical severity, timing, and imaging modality differed according to geography, specialty,and country income level. Over 80% of respondents agreed that further randomized clinical trials for BAO were warranted.Moreover, 45.6% of respondents indicated they would find it acceptable to enroll all trial-eligible patients into the medical armof a BAO trial, whereas 26.3% would not enroll.CONCLUSION:Most stroke physicians continue to believe in the efficacy of EVT in selected patients with BAO in spite of BEST andBASICS. There is no consensus on which selection criteria to use, and few clinicians would use anterior circulation occlusioncriteria for BAOs. Further randomized clinical trials for BAO are warranted.
Czech name
—
Czech description
—
Classification
Type
J<sub>ost</sub> - Miscellaneous article in a specialist periodical
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Stroke: Vascular and Interventional Neurology
ISSN
2694-5746
e-ISSN
2694-5746
Volume of the periodical
2
Issue of the periodical within the volume
5
Country of publishing house
US - UNITED STATES
Number of pages
14
Pages from-to
"e000538"
UT code for WoS article
—
EID of the result in the Scopus database
—